Kim Y-I
It is better to err on the safe side and thus the broken line is placed 25% below the solid line which defines possible toxicity
To minimize treatment interruptions due to adverse reactions, subsequent Phase III clinical trials may adopt a more gradual dose-escalation strategy to reduce the incidence and severity of gastrointestinal discomfort and other adverse events, thereby enhancing patient tolerance and adherence to the medication
The specialists at Primary Care of Clear Lake assess each patients overall health, medical history, and specific weight loss goals to decide if tirzepatide is an appropriate option
In laboratory settings, researchers utilize this compound in in-vitro and biochemical model systems to examine dual-receptor agonism, pathway interaction, and peptide-mediated regulatory mechanisms associated with metabolic and endocrine signaling networks
Palmer SC, Tendal B, Mustafa RA et al (2021) Sodiumglucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
